A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji

A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji - the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031161

Enrollment

Registered

2018-04-01

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papuloerythroderma of Ofuji

Interventions

Irradiation frequency, once a day, three times a week or twice a week, and irradiating 24 times in total by 10 weeks. One dose shall be 1/2 of the minimum erythema dose.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with papuloerythroderma of Ofuji

Exclusion criteria

Exclusion criteria: 1.Patients with malignant tumor complications 2.Patient with complication of skin malignancy or previous medical history 3.Patients with high cancer risk 4.Patients diagnosed with eczema secondary erythroderma (senile erythroderma), chronic prurigo, atopic dermatitis, drug eruption, lichen planus, eosinophilia syndrome, cutaneous amyloidosis, cutaneous lymphoma , leukemia 5.Patients undergoing Cyclosporine oral administration, etretinate orally,immunosuppressive therapy treatment 6. patients undergoing oral corticosteroid treatment with 21 mg or more per day in terms of prednisolone 7.Patients whose usage, dose of oral treatment, topical treatment has been changed within 2 weeks 8.Patients taking drugs that cause photosensitivity, patients with outstanding photosensitivity 9.Patients who have received UVB ultraviolet radiation therapy within 3 months 10.Patients who participated in other clinical trials within 4 months 11.patients judged inappropriate

Design outcomes

Primary

Measure	Time frame
amaunt of change with Body Surface Area of erythema after irradiation 24 times amaunt of change with erythema and papules after irradiation 24 times	—

Countries

Japan

Contacts

Public ContactSatoshi Nishiyama

Kobe University Graduate School of Medicine Department of Dermatology

dermatol@med.kobe-u.ac.jp078-382-6134

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026